These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 30685678)

  • 61. Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study.
    Son KB; Bae S
    BMJ Open; 2019 Mar; 9(3):e026603. PubMed ID: 30842117
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Disparities in Metabolic Syndrome and Neurocognitive Function Among Older Hispanics/Latinos with Human Immunodeficiency Virus.
    Marquine MJ; Kamalyan L; Zlatar ZZ; Yassai-Gonzalez D; Perez-Tejada A; Umlauf A; Al-Rousan T; González V; Breton J; Guareña LA; Brody L; Cherner M; Ellis RJ; Zúñiga ML; Mungas DM; Moore RC; Moore DJ; Wojna V; Hall RK; Franklin DR; Heaton RK
    AIDS Patient Care STDS; 2024 May; 38(5):195-205. PubMed ID: 38662469
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X; Ejzykowicz F; Ramey DR; Sajjan S; Ambegaonkar BM; Mavros P; Tunceli K
    Clin Ther; 2015 Apr; 37(4):804-15. PubMed ID: 25626487
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Health services utilization for people with HIV infection: comparison of a population targeted for outreach with the U.S. population in care.
    Cunningham WE; Sohler NL; Tobias C; Drainoni ML; Bradford J; Davis C; Cabral HJ; Cunningham CO; Eldred L; Wong MD
    Med Care; 2006 Nov; 44(11):1038-47. PubMed ID: 17063136
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
    Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
    Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.
    Sicras-Mainar A; Sánchez-Álvarez L; Navarro-Artieda R; Darbà J
    Lipids Health Dis; 2018 Dec; 17(1):277. PubMed ID: 30522491
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differences between statins on clinical endpoints: a population-based cohort study.
    Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
    Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
    Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
    Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.
    Ahmed MH; Al-Atta A; Hamad MA
    Expert Opin Pharmacother; 2012 Sep; 13(13):1901-9. PubMed ID: 22770622
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia.
    Demoz GT; Wahdey S; Kasahun GG; Hagazy K; Kinfe DG; Tasew H; Bahrey D; Niriayo YL
    BMC Res Notes; 2019 Jul; 12(1):386. PubMed ID: 31288848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention.
    Wong C; Marrast L; Rasul R; Srivastava R; Kuvin J; Roswell R; Conigliaro J; Kim EJ
    PLoS One; 2024; 19(10):e0311724. PubMed ID: 39378232
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke.
    Valentino M; Al Danaf J; Panakos A; Ragupathi L; Duffy D; Whellan D
    Am Heart J; 2016 Nov; 181():130-136. PubMed ID: 27823684
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Estimated Cardiovascular Risk and Guideline-Concordant Primary Prevention With Statins: Retrospective Cross-Sectional Analyses of US Ambulatory Visits Using Competing Algorithms.
    Fairman KA; Romanet D; Early NK; Goodlet KJ
    J Cardiovasc Pharmacol Ther; 2020 Jan; 25(1):27-36. PubMed ID: 31353942
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Changes in the prevalence of statin use in Germany - findings from national health interview and examination surveys 1997-1999 and 2008-2011].
    Knopf HC; Busch MA; Du Y; Truthmann J; Schienkiewitz A; Scheidt-Nave C
    Z Evid Fortbild Qual Gesundhwes; 2017 May; 122():22-31. PubMed ID: 28511896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Impact of HIV-Related Stigma on Racial/Ethnic Disparities in Retention in HIV Care Among Adults Living with HIV in Florida.
    Forney DJ; Sheehan DM; Dale SK; Li T; De La Rosa M; Spencer EC; Sanchez M
    J Racial Ethn Health Disparities; 2024 Aug; 11(4):2498-2508. PubMed ID: 37495905
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.
    Mesgarpour B; Gouya G; Herkner H; Reichardt B; Wolzt M
    Lipids Health Dis; 2015 Oct; 14():131. PubMed ID: 26497728
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ethnic variations in lipid-lowering in response to a statin (EVIREST): a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Chapman N; Chang CL; Caulfield M; Dahlöf B; Feder G; Sever PS; Poulter NR
    Ethn Dis; 2011; 21(2):150-7. PubMed ID: 21749017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Statin use in Canadians: trends, determinants and persistence.
    Neutel CI; Morrison H; Campbell NR; de Groh M
    Can J Public Health; 2007; 98(5):412-6. PubMed ID: 17985686
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Factors associated with statin selection among privately insured commercial and Medicare patients.
    Zhao Z; Bae J; Sponseller CA; Zhu Y; Kryzhanovski VA; LeNarz LA
    Curr Med Res Opin; 2013 Apr; 29(4):395-404. PubMed ID: 23406054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.